Swenam Canadian Institute of Research & Innovation (Sciri) upholds a core value of fostering collaboration among scholars across local and international institutions, transcending disciplinary boundaries, and engaging with both society and industry. Distinguished by its multifaceted research endeavors in critical areas such as clean energy, genomics, cancer treatment, Drug Discovery & Medicinal Chemistry, Antibiotics Resistance and HCV treatment, Sciri stands at the forefront of national and international research landscapes.

 

At the heart of our research mission lies a commitment to collaboration with partners, essential for advancing knowledge and effecting positive change. This collaborative ethos extends to organizations, researchers, communities, and participants worldwide, enabling us to collectively push the boundaries of discovery and address pressing societal challenges. Through equitable partnerships, we forge enduring networks, bolster global research capacity, and cultivate a dynamic research ecosystem.

Our approach to collaboration and partnership is guided by five foundational principles:

  1. Pursuing Bold and Transformative Research: We collaborate to undertake groundbreaking research of exceptional caliber, striving to address the most significant societal challenges and make a meaningful impact on a global scale.
  2. Maintaining Independence and Integrity: Upholding academic independence, research excellence, and the highest standards of integrity are paramount in all our collaborations. We are committed to diversity, inclusion, and the dissemination of research free from undue influence, aligning with our charitable mission.
  3. Ensuring Safety and Security: We prioritize the safety and security of our researchers, collaborators, and participants, ensuring compliance with regulatory standards and fostering an environment conducive to confident and ethical research.
  4. Identifying and Mitigating Risks: Proactively identifying and managing risks, including reputational, ethical, and legal considerations, underscores our commitment to safeguarding intellectual assets and upholding human rights in all collaborative endeavors.
  5. Promoting Equitable Collaboration and Recognition: We advocate for equitable treatment and transparent recognition of contributions from all collaborators, regardless of geographic location. Emphasizing fair acknowledgment of financial and other support, we cultivate deep, mutually beneficial partnerships that enhance capacity building, particularly in low and middle-income countries.

In essence, our dedication to collaboration and partnership is foundational to our pursuit of transformative research aimed at addressing global challenges and improving lives worldwide.